Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium bromide plus budesonide for cardiopulmonary protection during thoracoscopic lobectomy
ChiCTR2200062521Phase 4Recruiting
- Sponsor
- Rizhao People's Hospital
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of glycopyrronium and budesonide in Perioperative cardiopulmonary dysfunction (PCPD) (4 arms), sponsored by Rizhao People's Hospital. Primary endpoints: Blood pressure, Heart rate and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
glycopyrroniumbudesonide
03
Conditions
Perioperative cardiopulmonary dysfunction (PCPD)
Beyond the preview
Go deeper on ChiCTR2200062521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062521.